Abstract luminous illustration of a melanocortin receptor-binding signaling lattice

Research digest

Melanotan 2 turns on the skin's own pigment switch without sunlight — and the same switch is wired to appetite, arousal, and a real list of harms.

A forward-looking, candid digest of what the melanocortin literature actually reports about this peptide: the effects people chase, and the renal, vascular, and skin-cancer signals the case reports keep raising.

The short version

Melanotan 2 is a lab-made copy of a natural hormone your body uses to make skin pigment. Injected under the skin, it flips on the cells that produce melanin, so people tan with little or no sun. The same signal also dials down appetite and, in men, can trigger spontaneous erections — which is why this one peptide gets used for three very different reasons.

The upside is real and so is the downside. Small early human studies confirmed the tanning and erection effects. But Melanotan 2 has never been approved as a medicine anywhere, the products sold online are unregulated, and the published case reports are serious: new and changing moles, melanoma, kidney injury, prolonged painful erections, and brain swelling. The honest summary is that it works the way the biology predicts — and that what people report, including the downsides, is on the effects page.

What the Melanotan 2 literature actually shows

Melanotan 2 (also written Melanotan II, MT-II, or MT-2) is a cyclic synthetic analog of alpha-melanocyte-stimulating hormone (alpha-MSH) — the body's own pigment-signaling peptide. It was engineered at the University of Arizona in the late 1980s to be more potent and more durable than the natural hormone [1]. It is a non-selective agonist of the melanocortin receptors MC1R through MC5R, which is the single fact that explains why it does so many different things at once [1].

The headline pharmacology is clean. Activate MC1R on a melanocyte (a pigment cell) and you raise cyclic AMP (cAMP, a cell's internal "go" signal), which drives the master pigment gene MITF and ramps up melanin production — a tan with no ultraviolet light required [1]. In a 1996 pilot Phase I study, three healthy men given escalating subcutaneous doses showed measurable facial and body pigmentation after only five low doses [1]. Those numbers are study-design facts, not a dosing guide: Melanotan 2 is not approved for human use.

The same receptor family, in the brain, is wired to appetite and sexual function — which is the source of both the effects people seek and several of the harms documented later on this site.

The effect that made it famous, and the one that surprised everyone

The tanning was the design goal. The erections were the surprise. In the original Phase I tanning work, the volunteers reported spontaneous erections lasting one to five hours alongside the pigmentation [1] — an unplanned finding that pointed researchers straight at the brain's melanocortin circuitry.

That observation launched a second line of research. In a double-blind, placebo-controlled crossover study of ten men with psychogenic erectile dysfunction, a single subcutaneous dose produced clinically apparent erections in eight of ten men; mean duration of firm rigidity was 38.0 minutes versus 3.0 minutes on placebo [2]. The effect is central — it runs through the brain, not the blood vessels — which is what distinguishes this peptide family from conventional erectile-dysfunction drugs [3]. The same scaffold was later optimized into a separate, approved sexual-function melanocortin agonist; that approval does not apply to Melanotan 2, which remains unapproved [3].

Why this site leads with the risks

Most Melanotan 2 content online sells a tan and skips the case reports. This digest does the opposite. Because the peptide switches on pigment cells everywhere, the dermatology literature documents melanotan 2 side effects that include new moles, darkening of existing moles, dysplastic (atypical) nevi, and case reports of melanoma in users [11][4]. The toxicology literature adds rhabdomyolysis with kidney injury and a documented case of renal infarction [5][6]. There are case reports of priapism — a prolonged, dangerous erection — and of posterior reversible encephalopathy syndrome, a form of brain swelling [19].

None of this means the effects people want aren't real; it means the same potent signaling carries a real bill. The full picture of the melanotan 2 dangers and the published Melanotan 2 research sit side by side here, every quantitative claim tied to a study in the Melanotan 2 references.